Activation of nuclear factor κB and induction of inducible nitric oxide synthase by Ureaplasma urealyticum in macrophages

Infection and Immunity

Volumn 68, Issue 12, 2000, Pages 7087-7093

  Li, Y H ^a   Yan, Z Q ^a   Jensen, J Skov ^b   Tullus, K ^a   Brauner, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; CHRONIC LUNG DISEASE; DRUG EFFECT; ENZYME INDUCTION; LUNG ALVEOLUS MACROPHAGE; NEWBORN DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UREAPLASMA UREALYTICUM;

ANIMALS; ANTIGENS, BACTERIAL; BUDESONIDE; CELL LINE; DEXAMETHASONE; MACROPHAGES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OMEGA-N-METHYLARGININE; RATS; UREAPLASMA UREALYTICUM;

EID: 0034445517     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.12.7087-7093.2000     Document Type: Article

References (43)

1. Abele-Horn, M., J. Peters, O. Genzel-Boroviczeny, C. Wolff, A. Zimmermann, and W. Gottschling. 1997. Vaginal Ureaplasma urealyticum colonization: influence on pregnancy outcome and neonatal morbidity. Infection 25:286-291.
2. Aikio, O., K. Vuopala, M. L. Pokela, and M. Hallman. 2000. Diminished inducible nitric oxide synthase expression in fulminant early-onset neonatal pneumonia. Pediatrics 105:1013-1019.
3. Ajizian, S. J., B. K. English, and E. A. Meals. 1999. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J. Infect. Dis. 179:939-944.
4. Bancalari, E. 1998. Corticosteroids and neonatal chronic lung disease. Eur. J. Pediatr. 157:S31-S37.
5. Beckman, J. S., T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87:1620-1624.
6. Chen, F., V. Castranova, X. Shi, and L. M. Demers. 1999. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin. Chem. 45:7-17.
7. Christman, J. W., L. H. Lancaster, and T. S. Blackwell. 1998. Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med. 24:1131-1138.
8. Evans, T., A. Carpenter, H. Kinderman, and J. Cohen. 1993. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ. Shock 41:77-81.
9. Fang, F. C. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 99:2818-2825.
10. Grisham, M. B., D. Jourd'Heuil, and D. A. Wink. 1999. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites implications in inflammation. Am. J. Physiol. 276:G315-G321.
11. Hierholzer, C., B. Harbrecht, J. M. Menezes, J. Kane, J. MacMicking, C. F. Nathan, A. B. Peitzman, T. R. Billiar, and D. J. Tweardy. 1998. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J. Exp. Med. 187:917-928.
12. Kotecha, S. 1996. Cytokines in chronic lung disease of prematurity. Eur. J. Pediatr. 155:S14-S17.
13. Kruger, T., and J. Baier. 1997. Induction of neutrophil chemoattractant cytokines by Mycoplasma hominis in alveolar type II cells. Infect. Immun. 65:5131-5136.
14. Lee, J. I., and G. J. Burckart. 1998. Nuclear factor kappa B: important transcription factor and therapeutic target. J. Clin. Pharmacol. 38:981-993.
15. Li, Y.-H., A. Brauner, B. Jonsson, I. Van der Ploeg, O. Söder, M. Holst, J. Skov Jensen, H. Lagercrantz, and K. Tullus. 2000. Ureaplasma urealyticum induced production of proinflammatory cytokines by macrophages. Pediatr. Res. 48:114-119.
16. Lorsbach, R. B., W. J. Murphy, C. J. Lowenstein, S. H. Snyder, and S. W. Russell. 1993. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J. Biol. Chem. 268:1908-1913.
17. Murphy, M. P. 1999. Nitric oxide and cell death. Biochim. Biophys. Acta 1411:401-414.
18. Orman, K. L., J. L. Shenep, and B. K. English. 1998. Pneumococci stimulate the production of the inducible nitric oxide synthase and nitric oxide by murine macrophages. J. Infect. Dis. 178:1649-1657.
19. Ozdemir, A., M. A. Brown, and W. J. Morgan. 1997. Markers and mediators of inflammation in neonatal lung disease. Pediatr. Pulmonol. 23:292-306.
20. Panaro, M. A., A. Acquafredda, S. Lisi, D. D. Lofrumento, T. Trotta, R. Satalino, M. Saccia, V. Mitolo, and O. Brandonisio. 1999. Inducible nitric oxide synthase and nitric oxide production in Leishmania infantum-infected human macrophages stimulated with interferon-gamma and bacterial lipopolysaccharide. Int. J. Clin. Lab. Res. 29:122-127.
21. Perzigian, R. W., J. T. Adams, G. M. Weiner, M. A. Dipietro, L. K. Blythe, C. L. Pierson, and R. G. Faix. 1998. Ureaplasma urealyticum and chronic lung disease in very low birth weight infants during the exogenous surfactant era. Pediatr. Infect. Dis. J. 17:620-625.
22. Pierce, M. R., and E. Bancalari. 1995. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr. Pulmonol. 19:371-378.
23. Rudd, P. T., G. H. Cassell, K. B. Waites, J. K. Davis, and L. B. Duffy. 1989. Ureaplasma urealyticum pneumonia: experimental production and demonstration of age-related susceptibility. Infect. Immun. 57:918-925.
24. Schroeder, R. A., C. Cai, and P. C. Kuo. 1999. Endotoxin-mediated nitric oxide synthesis inhibits IL-1β gene transcription in ANA-1 murine macrophages. Am. J. Physiol. 277:C523-C530.
25. Sirsjo, A., P. Soderkvist, T. Sundqvist, M. Carlsson, M. Ost, and A. Gidlof. 1994. Different induction mechanisms of mRNA for inducible nitric oxide synthase in rat smooth muscle cells in culture and in aortic strips. FEBS Lett. 338:191-196.
26. Sketelj, J., N. Crne-Finderle, B. Strukelj, J. V. Trontelj, and D. Pette. 1998. Acetylcholinesterase mRNA level and synaptic activity in rat muscles depend on nerve-induced pattern of muscle activation. J. Neurosci. 18:1944-1952.
27. Sonoda, M., J. Kobayashi, M. Takezawa, T. Miyazaki, T. Nakajima, H. Shimomura, K. Koike, A. Satomi, H. Ogino, R. Omoto, and T. Komoda. 1997. An assay method for nitric oxide-related compounds in whole blood. Anal. Biochem. 247:417-427.
28. Stancombe, B. B., W. F. Walsh, S. Derdak, P. Dixon, and D. Hensley. 1993. Induction of human neonatal pulmonary fibroblast cytokines by hyperoxia and Ureaplasma urealyticum. Clin. Infect. Dis. 17:S154-S157.
29. Takasaki, J., and Y. Ogawa. 1999. Interleukin 8 in the tracheobronchial aspirate of infants acts as a neutrophil chemolactic factor in the development of chronic lung disease. Pediatr. Int. 41:78-81.
30. Taylor, M. J., H. F. Cross, and K. Bilo. 2000. Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria. J. Exp. Med. 191:1429-1435.
31. Thiemermann, C. 1997. Nitric oxide and septic shock. Gen. Pharmacol. 29:159-166.
32. Tullus, K., G. W. Noack, L. G. Burman, R. Nilsson, B. Wretlind, and A. Brauner. 1996. Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur. J. Pediatr. 155:112-116.
33. van Waarde, W. M., F. Brus, A. Okken, and J. L. Kimpen. 1997. Ureaplasma urealyticum colonization, prematurity and bronchopulmonary dysplasia. Eur. Respir. J. 10:886-890.
34. Waites, K. B., D. T. Crouse, and G. H. Cassell. 1993. Systemic neonatal infection due to Ureaplasma urealyticum. Clin. Infect. Dis. 17:S131-S135.
35. Walsh, W. F., J. Butler, J. Coalson, D. Hensley, G. H. Cassell, and R. A. deLemos. 1993. A primate model of Ureaplasma urealyticum infection in the premature infant with hyaline membrane disease. Clin. Infect. Dis. 17:S158-S162.
36. Wang, E. E., A. Ohlsson, and J. D. Kellner. 1995. Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a metaanalysis. J. Pediatr. 127:640-644.
37. Weinberg, J. B. 1998. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol. Med. 4:557-591.
38. Wheeler, M. A., S. D. Smith, G. Garcia-Cardena, C. F. Nathan, R. M. Weiss, and W. C. Sessa. 1997. Bacterial infection induces nitric oxide synthase in human neutrophils. J. Clin. Invest. 99:110-116.
39. Williams, C. M., and J. W. Coleman. 1995. Induced expression of mRNA for IL-5, IL-6, TNF-alpha, MIP-2 and IFN-gamma in immunologically activated rat peritoneal mast cells: inhibition by dexamethasone and cyclosporin A. Immunology 84:244-249.
40. Wong, H. R., J. A. Carcillo, G. Burckart, and S. S. Kaplan. 1996. Nitric oxide production in critically ill patients. Arch. Dis. Child. 74:482-489.
41. Xie, Q. W., H. J. Cho, J. Calaycay, R. A. Mumford, K. M. Swiderek, T. D. Lee, A. Ding, T. Troso, and C. Nathan. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228.
42. Xie, Q. W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705-4708.
43. Yan, Z., A. Sirsjo, M. L. Bochaton-Piallat, G. Gabbiani, and G. K. Hansson. 1999. Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation. Arterioscler. Thromb. Vasc. Biol. 19:2854-2862.